Difficulty: Medium
Average Score: 93%
Practice
Chylomicron is:
Correct answer
D
Rationale
The correct answer is D) Large lipoprotein particle that is created by the absorptive cells of the small intestine. It transports lipids to adipose tissue where they are broken down by lipoprotein lipase.
Chylomicrons are unique lipoproteins formed in the small intestine after the ingestion of dietary fats. They are essential for the absorption and transport of dietary triglycerides and other lipids through the lymphatic system and into the bloodstream. Chylomicrons play a crucial role in lipid metabolism by delivering dietary fats to adipose tissue and muscles for energy production or storage.
Option A is incorrect because chylomicrons are not associated with a decreased risk of atherosclerosis and are not called alpha-lipoprotein. Option B is also incorrect as it describes very low-density lipoproteins (VLDLs), not chylomicrons. Option C is misleading as it associates chylomicrons with high cholesterol levels and refers to them as beta-lipoproteins, which is incorrect.
Understanding the role of chylomicrons in lipid transport is crucial in safety pharmacology as it impacts drug absorption, distribution, and metabolism. By grasping the function of chylomicrons, healthcare professionals can better comprehend how certain medications may interact with lipid metabolism pathways, leading to safer and more effective pharmacological interventions.
Chylomicrons are unique lipoproteins formed in the small intestine after the ingestion of dietary fats. They are essential for the absorption and transport of dietary triglycerides and other lipids through the lymphatic system and into the bloodstream. Chylomicrons play a crucial role in lipid metabolism by delivering dietary fats to adipose tissue and muscles for energy production or storage.
Option A is incorrect because chylomicrons are not associated with a decreased risk of atherosclerosis and are not called alpha-lipoprotein. Option B is also incorrect as it describes very low-density lipoproteins (VLDLs), not chylomicrons. Option C is misleading as it associates chylomicrons with high cholesterol levels and refers to them as beta-lipoproteins, which is incorrect.
Understanding the role of chylomicrons in lipid transport is crucial in safety pharmacology as it impacts drug absorption, distribution, and metabolism. By grasping the function of chylomicrons, healthcare professionals can better comprehend how certain medications may interact with lipid metabolism pathways, leading to safer and more effective pharmacological interventions.